Eye (London, England)
Aflibercept vs ranibizumab biosimilars: manufacturing differences that might matter in the long run.
Ashish Sharma, Francesco Bandello, Sanjay Bandyopadhyay, Nilesh Kumar, Nikulaa Parachuri
Published: 202610.1038/s41433-025-04167-5
No abstract available for this study.